Last updated: July 12, 2017
| CMS Measure ID: | CMS144v5 |
|---|---|
| Version: | 5 |
| NQF Number: | 2908 |
| Measure Description: |
Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge |
| Initial Patient Population: |
All patients aged 18 years and older with a diagnosis of heart failure |
| Denominator Statement: |
Equals Initial Population with a current or prior LVEF < 40% |
| Denominator Exclusions: |
None |
| Numerator Statement: |
Patients who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge |
| Numerator Exclusions: |
Not Applicable |
| Denominator Exceptions: |
Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons) Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons) Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the healthcare system) |
| Measure Steward: | PCPI(R) Foundation (PCPI[R]) |
| Domain: | Effective Clinical Care |
| Next Version: | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| Previous Version: | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| Improvement Notation: |
Higher score indicates better quality |
| Guidance: |
LVEF < 40% corresponds to qualitative documentation of moderate dysfunction or severe dysfunction. To satisfy this measure, it must be reported for all heart failure patients at least once during the measurement period if seen in the outpatient setting. If the patient has an eligible inpatient discharge during the measurement period, as defined in the measure logic, it is expected to be reported at each hospital discharge. Beta-blocker therapy: -For patients with prior LVEF < 40%, beta-blocker therapy should include bisoprolol, carvedilol, or sustained release metoprolol succinate. The requirement of Count >=2 of Encounter, Performed is to establish that the eligible professional has an existing relationship with the patient. |
| eMeasure NQF: | 2908 |
| Quality ID: | 8 |
| High Priority Measure: | No |
| Data Submission Method: | EHR,Registry |
| Specialty Measure Set: | Cardiology,Hospitalists,General Practice/Family Medicine |
Specifications
Release Notes
Header
Updated Copyright.
Section: Copyright
Source: Annual Update
Updated Disclaimer.
Section: Disclaimer
Source: Measure Lead
Incremented eMeasure Version number.
Section: eMeasure Version number
Source: Annual Update
Updated Measure Developer.
Section: Measure Developer
Source: Measure Lead
Updated Measure Steward.
Section: Measure Steward
Source: Measure Lead
Updated NQF Number to '2908'. As of February 2016, this measure is endorsed by NQF as an eMeasure and has been assigned a new NQF number.
Section: NQF Number
Source: Measure Lead
Logic
Replaced datatypes 'Diagnosis, Active; Diagnosis, Inactive; Diagnosis, Resolved' with the re-specified 'Diagnosis' datatype to conform to QDM 4.2 changes.
Section: Denominator
Source: QDM Standards
Replaced datatypes 'Diagnosis, Active; Diagnosis, Inactive; Diagnosis, Resolved' with the re-specified 'Diagnosis' datatype to conform to QDM 4.2 changes.
Section: Denominator Exceptions
Source: QDM Standards
Replaced datatypes 'Diagnosis, Active; Diagnosis, Inactive; Diagnosis, Resolved' with the re-specified 'Diagnosis' datatype to conform to QDM 4.2 changes.
Section: Initial Population
Source: QDM Standards
Replaced datatypes 'Diagnosis, Active; Diagnosis, Inactive; Diagnosis, Resolved' with the re-specified 'Diagnosis' datatype to conform to QDM 4.2 changes.
Section: QDM Data Elements
Source: QDM Standards
Value Set
Value set Allergy to Beta Blocker Therapy (2.16.840.1.113883.3.526.3.1177): Deleted 1 SNOMEDCT code (407577009).
Section: None
Source: None
Value set Asthma (2.16.840.1.113883.3.526.3.362): Added 9 SNOMEDCT codes (707445000, 707446004, 707447008, 708038006, 708090002, 708093000, 708094006, 708095007, 708096008) and deleted 7 SNOMEDCT codes (233681001, 233685005, 266364000, 427354000, 57546000, 59327009, 91340006).
Section: None
Source: None
Value set Beta Blocker Therapy (2.16.840.1.113883.3.526.3.1174): Added 16 RXNORM codes and deleted 4 RXNORM codes (856412, 896974, 896975, 896976).
Section: None
Source: None
Value set Beta Blocker Therapy Ingredient (2.16.840.1.113883.3.526.3.1493): Deleted 1 RXNORM code (689716).
Section: None
Source: None
Value set Medical Reason (2.16.840.1.113883.3.526.3.1007): Deleted 1 SNOMEDCT code (161590003).
Section: None
Source: None
Value set Patient Reason (2.16.840.1.113883.3.526.3.1008): Deleted 1 SNOMEDCT code (5015009).
Section: None
Source: None